Sveriges mest populära poddar

Project Medtech

Project Medtech

Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic

55 min•12 juni 2023

Om avsnittet

In this episode, James Hamet at Vistim Labs and Duane Mancini discuss licensing technology from a university, voice of customer, neurodegenerative diseases, the importance of your economic story, why they are focusing on clinical data, and so much more.
James Hamet LinkedIn
Vistim Labs Website
Project Medtech Website
Project Medtech LinkedIn
Duane Mancini LinkedIn

Fler avsnitt

Episode 279 | Melissa Muller, Founder & Principal Consultant at Muller Advisory Company | The First Five Things Medtech Founders Need to Know Before They Scale

Episode 278 | Staci Miller, Founder of Gen UX Consulting | The First Five Things You Need to Know About Human Factors Validation Testing

Episode 277 | Merom Klein, Principal at Courage Growth Partners | Building Courage in Medtech: Turning Fear Into Adoption, Investment & Innovation

Episode 276 | Ashkon Rasooli, Founder & CEO of EnGenius Solutions LLC | Beyond Compliance: Building Quality Systems That Give Medtech Companies an Edge

Episode 275 | Shannon Clark, Founder & President of HavenSafe | From Human Factors to Ending Homelessness

Episode 274 | Joe Tumolo, Founder & President at JTSC | Why Relationships Win in MedTech Commercialization

Episode 273 | Caron Trumbo, Vice President of Operations at VirginiaBio | Building a Biotech Ecosystem That Actually Works

Episode 272 | Mike Monovoukas, CEO & Co-founder at AcuityMD | The Future of Medtech Commercialization: AI, Data, and Smarter Growth

Episode 271 | Christopher Gates, Founder & CEO of arsMedSecurity | The First Five Things You Need to Know About Medical Device Cybersecurity

Episode 270 | Franco Kraiselburd, Founder & CEO, Asclepii | Reimagining Wound Care Through Accessible Innovation

Project Medtech med Project Medtech finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.